Astrocyte Pharmaceuticals

📍 Groton, United States👥 13 employees💰 Last funded Dec 2025
Biotechnology Research🌐 astrocytepharma.com
Website LinkedIn
Astrocyte Pharmaceuticals is a clinical-stage drug discovery and development company dedicated to accelerating the recovery and well-being of brain injury patients. Astrocyte is committed to proving the neuro- and cerebroprotective benefits of enhanced mitochondrial energy production in astrocytes, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke, TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
5
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
United States
3
United Kingdom
1
Thailand
1
Investor activity2017–2025 · investors recorded per year
201712020220252
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Astrocyte Pharmaceuticals?
Astrocyte Pharmaceuticals has 5 investors on record on gritt.io.
When did Astrocyte Pharmaceuticals last raise funding?
The most recent investment in Astrocyte Pharmaceuticals recorded on gritt.io was in December 2025.
What industry is Astrocyte Pharmaceuticals in?
Astrocyte Pharmaceuticals operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Astrocyte Pharmaceuticals based?
Astrocyte Pharmaceuticals is headquartered in Groton, United States.